Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
38,466,645
-
Total 13F shares
-
8,528,460
-
Share change
-
-247,285
-
Total reported value
-
$134,015,000
-
Price per share
-
$15.74
-
Number of holders
-
49
-
Value change
-
-$11,645,346
-
Number of buys
-
24
-
Number of sells
-
14
Institutional Holders of Protara Therapeutics, Inc. - Common Stock (TARA) as of Q1 2021
As of 31 Mar 2021,
Protara Therapeutics, Inc. - Common Stock (TARA) was held by
49 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,528,460 shares.
The largest 10 holders included
Opaleye Management Inc., Rock Springs Capital Management LP, Ikarian Capital, LLC, VANGUARD GROUP INC, ORBIMED ADVISORS LLC, PERCEPTIVE ADVISORS LLC, Artisan Partners Limited Partnership, FRANKLIN RESOURCES INC, Cormorant Asset Management, LP, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
49
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.